First, chronic hyperinsulinemia, a hallmark of early insulin resistance, desensitizes the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway in skeletal muscles, thereby impairing protein synthesis, muscle stem cell activation, and mitochondrial biogenesis [32,33]. The gene discussed is AKT1; the disease is Hyperinsulinemia.